Una-Theses-0796.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
An Investigation of the Crystal Growth of Heavy Sulfides in Supercritical
AN ABSTRACT OF THE THESIS OF LEROY CRAWFORD LEWIS for the Ph. D. (Name) (Degree) in CHEMISTRY presented on (Major) (Date) Title: AN INVESTIGATION OF THE CRYSTAL GROWTH OF HEAVY SULFIDES IN SUPERCRITICAL HYDROGEN SULFIDE Abstract approved Redacted for privacy Dr. WilliarriIJ. Fredericks Solubility studies on the heavy metal sulfides in liquid hydrogen sulfide at room temperature were carried out using the isopiestic method. The results were compared with earlier work and with a theoretical result based on Raoult's Law. A relative order for the solubilities of sulfur and the sulfides of tin, lead, mercury, iron, zinc, antimony, arsenic, silver, and cadmium was determined and found to agree with the theoretical result. Hydrogen sulfide is a strong enough oxidizing agent to oxidize stannous sulfide to stannic sulfide in neutral or basic solution (with triethylamine added). In basic solution antimony trisulfide is oxi- dized to antimony pentasulfide. In basic solution cadmium sulfide apparently forms a bisulfide complex in which three moles of bisul- fide ion are bonded to one mole of cadmium sulfide. Measurements were made extending the range over which the volumetric properties of hydrogen sulfide have been investigated to 220 °C and 2000 atm. A virial expression in density was used to represent the data. Good agreement, over the entire range investi- gated, between the virial expressions, earlier work, and the theorem of corresponding states was found. Electrical measurements were made on supercritical hydro- gen sulfide over the density range of 10 -24 moles per liter and at temperatures from the critical temperature to 220 °C. Dielectric constant measurements were represented by a dielectric virial ex- pression. -
RFC: IRIS Barium and Compounds Substance File
October 29, 2002 Information Quality Guidelines Staff Mail Code 28221T U.S. EPA 1200 Pennsylvania Ave., N.W. Washington, DC, 20460 Subject: Request for Correction of the IRIS Barium and Compounds substance file - Information disseminated by EPA that does not comply with EPA or OMB Information Quality Guidelines Dear Madam or Sir; Chemical Products Corporation (CPC), a Georgia corporation which produces Barium and Strontium chemicals at its Cartersville, Georgia facility, hereby submits this Request for Correction (RFC) concerning EPA’s Integrated Risk Information System Barium and Compounds Substance File (IRIS Ba File). The influential information contained in this file fails to comply with the OMB “Guidelines for Ensuring and Maximizing the Quality, Objectivity, Utility, and Integrity of Information Disseminated by Federal Agencies”. The information disseminated in EPA’s IRIS Barium and Compounds file directly contradicts the information published by EPA in the January 3, 1997 Federal Register and, therefore, cannot represent an EPA consensus position. The IRIS Ba File was revised in 1998 and 1999, yet it contains no mention of the toxicological evaluation conducted by EPA’s Office of Pollution, Pesticides, and Toxic Substances reported in 62 FR 366-372 (No. 2, January 3, 1997). There is no explanation of how a radically different interpretation of the same data could be justified. The NOAEL employed to calculate the Oral Reference Dose in the IRIS Ba File is 0.21 mg/kg/day; there is no LOAEL associated with this NOAEL. The NOAEL reported in 62 FR 366-372 is 70 mg/kg/day in rats and 165 mg/kg/day in mice; these values are taken from a National Toxicology Program technical report and are associated with a LOAEL of 180 mg/kg/day. -
Thermoplastic Composite Chemical Compatibility Guide
123 WR ®300/525/600, AR ®HT & ARLON ® 1000 Chemical Resistance Data WR®300/525, AR®HT Concentrate & ARLON® 1000 Chemical Weight % <275°F (135°C) >275°F (135°C) WR®600 Comments Acetaldehyde, aq. 40 111 Acetamide, aq. 50 111 Acetic Acid, aq. 10 111 Acetic Acid, glacial 100 121 Acetic Anhydride 11Material 1 may react with absorbed moisture Acetone 1 2 – 3 1 Mechanical properties loss <30% for material 2 at T>120 ºF (50 ºC) Acetonitrile 11 Acetophenone 2 3 – 4 1 Material 1 may be slightly soluble at temperatures >390ºF (200ºC) Acetylene 11 Acetyl Chloride, dry 11Material 1 may react with absorbed moisture Acids-Aliphatic, pure 1 1 – 2 1 Acids-Sulfonic, pure 2 – 4 3 – 4 1 Acids-Non oxidizing, aq. <40 1 1 – 2 1 Acrylic Acid 111 Acrylonitrile 11 Adipic Acid 11 Air 1 2 – 3 1 Oxidation for material 1 increases at higher temperatures Alcohols, Aliphatic 111 Allyl Chloride 2 2 – 3 1 Allyl Alcohol 111 Aluminum Chloride, aq. 10 111 Aluminum Chloride, anydrous 441 Aluminum Nitrate, aq. Sat. 11 Aluminum Sulfate, aq. 10 111 Ammonia, aq. Conc. 111 Ammonia, Liquid 11 Ammonia Gas 111 Ammonium Carbonate, aq. 10 111 Ammonium Chloride, aq. 10 111 Ammonium Chloride, aq. 37 111 Ammonium Fluoride, aq. Sat. 11 Ammonium Hydroxide 11 Notes: Material 1= WR300, WR525, ARHT & Arlon 1000 Material 2= WR600 www.gtweed.com WR®300/525, AR®HT Concentrate & ARLON® 1000 Chemical Weight % <275°F (135°C) >275°F (135°C) WR®600 Comments Ammonium Nitrate, aq. Sat. 11 Ammonium Phosphate, aq. Sat. -
Toxicological Profile for Barium and Barium Compounds
TOXICOLOGICAL PROFILE FOR BARIUM AND BARIUM COMPOUNDS U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Agency for Toxic Substances and Disease Registry August 2007 BARIUM AND BARIUM COMPOUNDS ii DISCLAIMER The use of company or product name(s) is for identification only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry. BARIUM AND BARIUM COMPOUNDS iii UPDATE STATEMENT A Toxicological Profile for Barium and Barium Compounds, Draft for Public Comment was released in September 2005. This edition supersedes any previously released draft or final profile. Toxicological profiles are revised and republished as necessary. For information regarding the update status of previously released profiles, contact ATSDR at: Agency for Toxic Substances and Disease Registry Division of Toxicology and Environmental Medicine/Applied Toxicology Branch 1600 Clifton Road NE Mailstop F-32 Atlanta, Georgia 30333 BARIUM AND BARIUM COMPOUNDS iv This page is intentionally blank. v FOREWORD This toxicological profile is prepared in accordance with guidelines developed by the Agency for Toxic Substances and Disease Registry (ATSDR) and the Environmental Protection Agency (EPA). The original guidelines were published in the Federal Register on April 17, 1987. Each profile will be revised and republished as necessary. The ATSDR toxicological profile succinctly characterizes the toxicologic and adverse health effects information for the hazardous substance described therein. Each peer-reviewed profile identifies and reviews the key literature that describes a hazardous substance's toxicologic properties. Other pertinent literature is also presented, but is described in less detail than the key studies. The profile is not intended to be an exhaustive document; however, more comprehensive sources of specialty information are referenced. -
Toxicological Profile for Antimony
ANTIMONY AND COMPOUNDS 11 CHAPTER 2. HEALTH EFFECTS 2.1 INTRODUCTION The primary purpose of this chapter is to provide public health officials, physicians, toxicologists, and other interested individuals and groups with an overall perspective on the toxicology of antimony. It contains descriptions and evaluations of toxicological studies and epidemiological investigations and provides conclusions, where possible, on the relevance of toxicity and toxicokinetic data to public health. When available, mechanisms of action are discussed along with the health effects data; toxicokinetic mechanistic data are discussed in Section 3.1. A glossary and list of acronyms, abbreviations, and symbols can be found at the end of this profile. To help public health professionals and others address the needs of persons living or working near hazardous waste sites, the information in this section is organized by health effect. These data are discussed in terms of route of exposure (inhalation, oral, and dermal) and three exposure periods: acute (≤14 days), intermediate (15–364 days), and chronic (≥365 days). As discussed in Appendix B, a literature search was conducted to identify relevant studies examining health effect endpoints. Figure 2-1 provides an overview of the database of studies in humans or experimental animals included in this chapter of the profile. These studies evaluate the potential health effects associated with inhalation, oral, or dermal exposure to antimony, but may not be inclusive of the entire body of literature. A systematic review of the scientific evidence of the health effects associated with exposure to antimony was also conducted; the results of this review are presented in Appendix C. -
Toxicological Profile for Zinc
TOXICOLOGICAL PROFILE FOR ZINC U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Agency for Toxic Substances and Disease Registry August 2005 ZINC ii DISCLAIMER The use of company or product name(s) is for identification only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry. ZINC iii UPDATE STATEMENT A Toxicological Profile for Zinc, Draft for Public Comment was released in September 2003. This edition supersedes any previously released draft or final profile. Toxicological profiles are revised and republished as necessary. For information regarding the update status of previously released profiles, contact ATSDR at: Agency for Toxic Substances and Disease Registry Division of Toxicology/Toxicology Information Branch 1600 Clifton Road NE Mailstop F-32 Atlanta, Georgia 30333 ZINC vi *Legislative Background The toxicological profiles are developed in response to the Superfund Amendments and Reauthorization Act (SARA) of 1986 (Public law 99-499) which amended the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA or Superfund). This public law directed ATSDR to prepare toxicological profiles for hazardous substances most commonly found at facilities on the CERCLA National Priorities List and that pose the most significant potential threat to human health, as determined by ATSDR and the EPA. The availability of the revised priority list of 275 hazardous substances was announced in the Federal Register on November 17, 1997 (62 FR 61332). For prior versions of the list of substances, see Federal Register notices dated April 29, 1996 (61 FR 18744); April 17, 1987 (52 FR 12866); October 20, 1988 (53 FR 41280); October 26, 1989 (54 FR 43619); October 17, 1990 (55 FR 42067); October 17, 1991 (56 FR 52166); October 28, 1992 (57 FR 48801); and February 28, 1994 (59 FR 9486). -
C09c - 2020.01
CPC - C09C - 2020.01 C09C TREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES (preparation of inorganic compounds or non-metallic elements C01; treatment of materials specially adapted to enhance their filling properties in mortars, concrete or artificial stone C04B 14/00, C04B 18/00, C04B 20/00); PREPARATION OF CARBON BLACK; {PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS} Definition statement This place covers: The treatment of inorganic compounds other than fibrous fillers, to enhance their pigmenting or filling properties; Preparation of carbon black. Preparation of inorganic materials being no single chemical compounds and used as pigments or fillers. References Limiting references This place does not cover: Treatment by polymerisation onto particle is classified in C08F 292/00. Only treatment by already polymerised agents is classified in C09C. Special rules of classification The following IPC groups are not used in the internal CPC classification scheme. Subject matter covered by these groups is classified in the following CPC groups: IPC group C09C1/68 is covered by CPC group C09K 3/14. Whenever in groups C09C 1/00 - C09C 1/66 the materials consist of a particulate core bearing a coating or any other deposit, classification is done only according to the composition of the core, unless otherwise stated, e.g. C09C 1/0015, C09C 1/0078. Preparations of materials which are no single chemical compounds, mainly comprising ceramic pigments (C09C 1/0009),consisting of solid solutions or polycristalline structures, and compounds defined as composite materials (C09C 1/0081).Preparation and treatment steps are not always easy to distinguish from each other, e.g. -
Barium Sulfate (Blanc Fixe) CAS No
Product Safety Summary Barium Sulfate (Blanc Fixe) CAS No. 7727-43-7 This Product Safety Summary is intended to provide a general overview of the chemical substance. The information on the summary is basic information and is not intended to provide emergency response information, medical information or treatment information. The summary should not be used to provide in-depth safety and health information. In-depth safety and health information can be found in the Safety Data Sheet (SDS) for the chemical substance. Names Barium sulfate (sulphate) Blanc Fixe Product Overview Solvay Fluorides, LLC does not sell barium sulfate directly to consumers. The barium sulfate sold by Solvay Fluorides, LLC is used in industrial applications and processes. Barium sulfate is used primarily as a whitening agent or as a support for other chemicals in industrial applications. Barium sulfate is sold as an odorless white solid. Barium sulfate is a relatively non-hazardous chemical. Any hazards are due primarily to the physical form (particles). Repeated or prolonged contact can irritate the skin and eyes. Breathing barium sulfate particles can irritate the nose and throat and restrict breathing (shortness of breath). Ingestion of large amounts of barium sulfate typically does not cause any problems. Manufacture of Product Solvay Fluorides, LLC imports the barium sulfate it sells from a Solvay affiliate in Europe. Solvay manufactures barium sulfate from barium containing ore. Barium is extracted from the ore as barium sulfide. The barium sulfide is reacted with sodium sulfate to form barium sulfate. The barium sulfate is further dried and purified to form the final product. -
United Nations ST/SG/AC.10/C.3/2018/105
United Nations ST/SG/AC.10/C.3/2018/105 Secretariat Distr.: General 5 September 2018 Original: English Committee of Experts on the Transport of Dangerous Goods and on the Globally Harmonized System of Classification and Labelling of Chemicals Sub-Committee of Experts on the Transport of Dangerous Goods Fifty-fourth session Geneva, 26 November-4 December 2018 Item 2 (c) of the provisional agenda Recommendations made by the Sub-Committee on its fifty-first, fifty-second and fifty-third sessions and pending issues: Listing, classification and packing Transport of barium carbonate as non-dangerous good Submitted by the expert from Spain* Introduction 1. Barium carbonate is a barium compound, and therefore by defect classified as UN 1564, BARIUM COMPOUND, N.O.S, in Division class 6.1. 2. Nevertheless, according to the information available, barium carbonate may not be toxic as can be shown by the information and tests provided. 3. To facilitate international trade and to avoid different interpretation of the applicable prescriptions for the transport of dangerous goods, it would be interesting to clearly exempt barium carbonates from the scope of the Model Regulations, as has already been done for Barium sulphate by special provision (SP) 177: “177 Barium sulphate is not subject to these Regulations.” 4. During the fifty-third session of the Sub-Committee, Spain submitted informal document INF.32, which included this proposal, justified by some test results for Barium Carbonate. Spain was asked to submit a formal document, taking into account the comments provided by the Sub-Committee experts (refer to ST/SG/AC.10/C.3/106 paragraphs 60-62), including additional test results for the barium carbonate from other sources of information. -
Antimony Trioxide [CAS No. 1309-64-4]
Antimony Trioxide [CAS No. 1309-64-4] Brief Review of Toxicological Literature Prepared for National Toxicology Program (NTP) National Institute of Environmental Health Sciences (NIEHS) National Institutes of Health U.S. Department of Health and Human Services Contract No. N01-ES-35515 Project Officer: Scott A. Masten, Ph.D. NTP/NIEHS Research Triangle Park, North Carolina Prepared by Integrated Laboratory Systems, Inc. Research Triangle Park, North Carolina July 2005 Chemical Name: Antimony Trioxide CAS RN: 1309-64-4 Formula: Sb2O3 Basis for Nomination: Antimony trioxide was nominated by the National Institute of Environmental Health Sciences for chronic toxicity, cardiotoxicity and carcinogenicity studies due to the potential for substantial human exposure in occupational settings and lack of adequate two-year exposure carcinogenicity studies. Additional studies of antimony trioxide are of interest, in lieu of studies with antimony trisulfide or another antimony compound, considering the higher volume of use and magnitude of human exposure, and the lack of two- year exposure carcinogenicity studies for any antimony compound by any route of administration. Antimony trisulfide was nominated to the NTP by the National Cancer Institute in 2002 for carcinogenicity studies (http://ntp.niehs.nih.gov/ntpweb/index.cfm?objectid=25BEBA08-BDB7-CEBA- FC56EAD78615ADCF). Subsequent to the nomination review process, the NTP concluded that antimony trisulfide should not be studied further at this time for the following reasons: 1) antimony trisulfide does not appear to represent a major form of antimony to which humans are exposed; 2) carcinogenicity studies of antimony trisulfide is unlikely to lead to a sufficient understanding of the carcinogenicity hazard for antimony compounds as a group; and 3) there is concern regarding the safe handling of pure antimony trisulfide in experimental settings due to its flammable/combustible nature. -
Barium Sulfide
Doc. No. SRC 51-48A Rev. 1 Rev. Date 5/2015 CHEMICAL PRODUCTS CORPORATION SDS No. 48A Revision Date May 12. 2015 GHS SAFETY DATA SHEET Page 1 of 8 Pages 1. IDENTIFICATION Product Name: Barium Sulfide , A l l G r a d e s SYNONYMS: Barium Sulfide, Grey; Barium Sulfide, Black Ash; Barium Monosulfide Recommended for industrial use as: • a component of depilatories for human hair removal • a raw material for the production of barium chemicals, • production of substances, • a component of articles added to provide x-ray opacity. Industrial uses advised against: None. MANUFACTURER: Chemical Products Corporation (CPC) P.O. Box 2470 102 Old Mill Road, S.E. Cartersville, Georgia 30120-1692 Telephone: 770-382-2144 Transportation Emergency: CHEMTREC 800-424-9300 2. HAZARD IDENTIFICATION Acute toxicity, Oral (Category 4), H302 WARNING HARMFUL IF SWALLOWED HARMFUL IF INHALED CAN CAUSE EYE AND SKIN IRRITATION Do not eat, drink or smoke when using this product. Wear protective gloves and eye protection. Use with adequate ventilation or wear a dust mask if excessive dust is present. Wash hands and face thoroughly after handling. Dispose of contents/container in accordance with local, state and federal regulations. CONTACT WITH ACID RELEASES POISONOUS AND FLAMMABLE HYDROGEN SULFIDE GAS. Alkalinity can cause burns to eyes and mucous membranes. Very toxic to aquatic organisms. Doc. No. SRC 51-48A Rev. 1 Rev. Date 5/2015 Chemical Products Corporation SDS No. 48A Page 2 of 8 pages Barium Sulfide, All Grades Carcinogenicity: NTP..........: No evidence of carcinogenicity. IARC.........: Not listed. OSHA........: Not regulated. Medical Conditions Aggravated by Exposure: None are known. -
Screening Assessment Report Template
Draft Screening Assessment Antimony-containing Substances Environment and Climate Change Canada Health Canada September 2018 Synopsis Pursuant to section 74 of the Canadian Environmental Protection Act, 1999 (CEPA), the Minister of the Environment and the Minister of Health have conducted a screening assessment of 11 substances referred to collectively as the Antimony-containing Substances Group. Substances in this group were identified as priorities for assessment as they met categorization criteria under subsection 73(1) of CEPA. The Chemical Abstracts Service Registry Numbers (CAS RN1), their Domestic Substances List (DSL) names and their common names are listed in the table below. Substances in the Antimony-containing Substances Group CAS RN DSL name Common name 1314-60-9 Antimony oxide (Sb2O5) Antimony pentoxide 1327-33-9a Antimony oxide Antimony oxide 1345-04-6 Antimony sulfide (Sb2S3) Antimony sulfide 10025-91-9 Stibine, trichloro- Antimony trichloride 1- 15432-85-6 Antimonate (SbO3 ), sodium Sodium antimonate Phosphorodithioic acid, O,O- 15874-48-3 NA dipropyl ester, antimony(3+) salt Antimony, Antimony 15890-25-2 tris(dipentylcarbamodithioato-S,S’)-, diamyldithiocarbamate (OC-6-11)- Antimony, tris[bis(2- 15991-76-1 ethylhexyl)carbamodithioato-S,S’]-, NA (OC-6-11)- Antimonate(2-), bis[µ-[2,3- di(hydroxy-κO)butanedioato(4-)- Antimony potassium 28300-74-5 κO1:κO4]]di-, dipotassium, trihydrate, tartrate (APT) stereoisomer 4- Antimonate (Sb2O7 ), 29638-69-5 Potassium antimonate tetrapotassium 1- Antimonate (Sb(OH)6 ), sodium, Sodium 33908-66-6 (OC-6-11)- hexahydroxoantimonate Abbreviations: NA, Not Available 1 The Chemical Abstracts Service Registry Number (CAS RN) is the property of the American Chemical Society and any use or redistribution, except as required in supporting regulatory requirements and/or for reports to the Government of Canada when the information and the reports are required by law or administrative policy, is not permitted without the prior, written permission of the American Chemical Society.